Been watching the market dynamics lately and there's something that's been nagging at me. Everyone's talking about whether a major correction is coming, and honestly, the data is starting to make me wonder if we should be paying closer attention.

Let me break down what I'm seeing. The CAPE ratio – that's the cyclically adjusted price-to-earnings metric – is sitting just under 40 right now. When I looked back at the historical numbers, the last time we hit these levels was right before the dot-com bubble imploded. That's not exactly comforting, especially when you consider how much weight AI stocks are carrying in the major indexes. The narrative around artificial intelligence is compelling, no doubt about it, but there's a real question about whether valuations have gotten ahead of reality.

Here's the thing though – nobody can actually predict when a market crash will happen. Anyone claiming they could would already be the wealthiest person alive. What we can do is prepare intelligently. And that means looking for opportunities in companies that the market might be overlooking right now.

I've been looking at some of the beaten-down sectors, and pharma is interesting. Take Pfizer as an example. The stock has taken a real hit in recent years because revenue's been inconsistent. On the surface, that looks risky. But dig deeper and you see something different. The company's facing some patent cliffs – Eliquis and Xtandi are losing exclusivity in the next couple years – but that's priced in already. What's not getting enough attention is their pipeline. They've got serious assets in oncology and weight management, areas that are actually growing. Plus they're using AI to trim costs.

What really caught my eye is the valuation. Pfizer's trading at 9 times forward earnings while the healthcare sector averages 18.6. That's a meaningful discount. If the market does crash and especially if it's driven by AI stock volatility, I'd expect Pfizer to hold up better than the mega-cap tech names. If it doesn't crash, the company's positioned to recover from its recent struggles anyway.

So here's my take: Whether or not a market crash actually happens in 2026, having exposure to fundamentally sound companies trading at reasonable prices seems like smart positioning. The uncertainty is real, but so are the opportunities if you're looking in the right places.